Articles & Insights
Duopharma Biotech maintains healthy profit growth in H1FY2026
Flavettes Celebrates Healthcare Heritage in Merdeka 2026 Campaign
Biocon Reinforces Commitment to Diabetes Care in Malaysia as Partner Duopharma Biotech Secures Insulin Tenders
Duopharma Biotech Contributes to National Pharmaceutical Self-Reliance Through Manufacturing Capacity and Portfolio Growth
Duopharma Biotech sees profit growth in Q1 FY2026 alongside insulin supply normalisation
Duopharma Biotech maintains robust revenue and profit growth momentum
Duopharma Biotech contributes RM300,000 to support Program Sekolah Angkat MADANI
Duopharma Biotech achieves strong profitability in Q3 FY2025
Duopharma Biotech showcases halal pharmaceutical production to SMIIC delegation
Duopharma Biotech appoints Group Chief Executive Officer
Duopharma Biotech sustains year-on-year profit growth in H1 FY2025
Duopharma Biotech Records New Milestone in Halal-Certified Treatments
Duopharma Biotech Maintains Focus on Domestic Market Leadership and International Growth
Duopharma Biotech Records 36.2% Revenue Growth and 67.8% Profit Improvement in Q1 FY2025
Duopharma Biotech Achieves Record Revenue With 15.5% Growth in 2024
Duopharma Biotech and Universiti Kebangsaan Malaysia Partner to Elevate Halal Standards in Healthcare
Duopharma Biotech records strong growth in Q3 FY2024
Duopharma Biotech Records Robust Financial Performance in Q2 2024
Duopharma Biotech Returns to Support Balanced Nutrition and Promote Healthy Breakfasts Among Schoolchildren
Duopharma Biotech Pursues Collaboration Opportunities in Qatar Outreach
Duopharma Biotech Pursues Growth Strategy Focusing on New Markets and Innovative Offerings
Duopharma Biotech brings Flavettes Glow to Indonesia
Duopharma Biotech optimistic on 2024 outlook with Q1FY2024 results
Duopharma Biotech forms R&D partnerships for new therapies
Duopharma Biotech partners Owen Mumford to distribute medical devices
Duopharma Biotech ends FY2023 with a marginal increase in revenue
Duopharma Biotech partners with Tourism Malaysia to boost immunity among travellers
Duopharma Biotech brings IRORO range to Australia with Tepanouits
Duopharma Biotech partners Renalworks to enhance dialysis services with innovative software
Nationwide campaign promoting balanced nutrition among school children officially concludes
Duopharma Biotech sees revenue recovery in Q3 FY2023
Duopharma Biotech Berhad elevates Halal Productivity with MYHALALGIG by Holistics Lab
Duopharma Biotech maintains revenue growth in 1H FY2023
Duopharma Biotech to invest up to USD 1 million in The Live Green Co
Duopharma Biotech to scale early lump detection across Malaysia
Duopharma Biotech to collaborate with Kensana Health for R&D and commercialisation of pain relief treatments
Duopharma Biotech maintains focus on portfolio expansion and corporate transformation
Duopharma Biotech Berhad opens Singapore office
Duopharma Biotech Partners With Respiree To Digitise COPD Patient Care
Duopharma Biotech Berhad Reports Strong Financial Performance in First Quarter of 2023
Duopharma Biotech Joins Nationwide Campaign to Promote Balanced Nutrition Among Schoolchildren
Duopharma Biotech Establishes PT Duopharma Healthcare Indonesia
Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management in Malaysia.
Duopharma Biotech Ends FY2022 With Highest revenue in Five Years
Duopharma Biotech Strengthens Good Governance with New Integrity Programme and Industry Recognition
Duopharma Biotech Records Milestone with First Halal-Certified Cancer Treatment
Duopharma Biotech Integrity and Anti-Corruption Series
Duopharma Biotech Sponsors the UNGCMYB GO ESG ASEAN 2022 Summit
Duopharma Biotech Records 10.33% Rise In Cumulative Revenue in 3Q 2022
Duopharma Biotech to Commercialise SCM Lifescience’s Stem Cell Based Hair Care Products in Malaysia and Region Under its Consumer Healthcare Business.
Duopharma Biotech Delivers Better Earnings in 2Q 2022
Duopharma Biotech And The Live Green Co To Develop Plant-Only Wellness Foods and Plant Based Pharmaceuticals in Malaysia
Duopharma Biotech Maintains High Productivity Amidst Focus on Innovation
Duopharma Biotech Spurs Efforts to Capture Global Halal Pharma Market via Halal Pharmaceuticals Symposium
Duopharma Biotech Posts Improved 1Q 2022 Performance
Duopharma Biotech Pledges Carbon Neutrality and Net Zero Goals ESG Roadmap Targets Carbon Neutrality to be Achieved by 2030 and Net Zero by 2050
Uphamol Signs on as Official Analgesic Partner For The Malaysian Football League
Proviton STR Signs on as Official Isotonic Partner for The Malaysian Football League
Duopharma Biotech Reports Higher 4Q 2021 Revenue Amidst Challenge of Higher Costs
Duopharma Biotech Launches New Flavettes Nutriskincare Range
Duopharma Biotech Posts Strong Growth in 3Q 2021
Duopharma Biotech Recognised at Sustainable Business Awards Malaysia 2020/21
Sinopharm Covid 19 Vaccine is Now Available in Malaysia
Duophama Biotech Reports Resilient 2Q 2021 Performance
Duopharma Biotech’s Shareholders Approve Issuance of 235 Million Bonus Shares at Company’s Fully-Virtual Meeting of Members
Duopharma Biotech Contributes RM1 Million to Malaysia’s Drive to Close Digital Learning Gap
Duopharma Biotech Granted Conditional Registration Approval for COVID 19 Sinopharm Vaccine
Duopharma Biotech Invests USD500,000 in NALURI to Further Empower Malaysia’s Digital Healthcare Vision
Duopharma Biotech Signs with the Government of Malaysia to Supply Russia’s COVID-19 Vaccine to Malaysia
Duopharma Biotech Maintains Forward Momentum with Robust Fundamentals
Duopharma Biotech Announces 1 for 3 Bonus Issue After Sterling 1st Quarter 2021
Duopharma Biotech Sets out to Expand Health and Beauty Range: Launch of Flavettes Effervescent Glamz
Duopharma Biotech CHAMPS® and Nasom CHAMPIONS Autism Awareness Fundraiser Featuring Art Crafted by Autism Children
Duopharma Biotech Fortifies Ethical Culture with ISO37001 Achievement and First Malaysia Pharma Company to Win BEIM FIVE Petals Gold Ethics Award
Duopharma Biotech Maintains Profit Momentum
Duopharma Biotech to Supply 6.4 Million Doses of The Russian COVID-19 Vaccine to The Nation
Duopharma Biotech Signs MOU with KPJ Healthcare Berhad to Collaborate Initiatives of Halal Pharmaceuticals
Duopharma Biotech Posts Another Strong Quarter Registering PBT of RM18.57 Million
Breast Cancer and Chronic Myloid Leukaemia Community Welcome Manufacturing og Relevant Drugs at Malaysia’s First HAPI Facility
Breast Cancer and Chronic Myloid Leukemia Community Welcome Manufacturing Relevant Drugs at Malaysia’s First HAPI Facility
Duopharma Biotech’s CHAMPS Joins Forces With Nasom To Propel Autism Awareness To A New Level In Malaysia
Duopharma Biotech to Manufacture its Second Oncology Medicine to Treat Chronic Myeloid Leukemia
Duopharma Biotech’s CHAMPS™ Joins Forces With NASOM To Propel Autism Awareness To A New Level In Malaysia
Duopharma Biotech To Manufacture Its Second Oncology Medicine To Treat Chronic Myeloid Leukemia
Duopharma Biotech Posts Creditable Q2 with PBT Climbing to RM19.39 Million
Halal Development Corporation, Duopharma Biotech and KPJ Join Forces to Boost The Global Halal Market in a Successful Webinar in conjunction with the World Halal Conference 2020
Venturetech Announces New RM15 Million Investment Through Triparte MOU with Duopharma Biotect BHD and Commercial Biosimilar Production Facility
VentureTECH Announce New RM15 Million Investment Through Triparte MOU with Duopharma Biotech Bhd and Pangen Biotech Inc. to Build Malaysia’s First Commercial Biosimilar Production Facility
Duopharma Biotech Maintains Positive Trajectory Despite Highly Challenging Environment
Duopharma Biotech Berhad Posts Robust Q1 2020 Results with PBT of RM17.73 Million on Increased Revenue of RM158.71 Million
Duopharma Biotech Invests USD250,000 in Naluri to Boost Malaysia’s Digital Health Vision
Duopharma Biotech Contributes RM500,000.00 Towards COVID 19 Fund
Duopharma Biotech Berhad Posts Commendable Q4 2019 Results with Gross Profit of RM52.19 million on revenue of RM137.76million
Duopharma Biotech Signs MOU with KPJ Healthcare Berhad to Collaborate in Development Initiatives of Halal Pharmaceuticals
Duopharma Biotech Records 14.52 per cent increase in revenue for nine months ended 30 September 2019
300 Kids Hone Their Tennis Skills at CHAMPS®-Sponsored ‘Tennis Malaysia First Serve Mini Tennis’
Duopharma Biotech Declares 1.0 Sen Interim Dividend for H1 FY2019
Negeri Sembilan Mufti gets First Hand Info on Manufacturing of Halal Pharmaceuticals